Inactief instrument

Andere talen Aastrom Biosciences Inc Nasdaq

Aandelen

US00253U3059

slotkoers Nasdaq Andere beurzen
- ^USD	-

08/05	Vericel minder verlies in Q1, meer inkomsten; vooruitzichten voor 2024 verhoogd -- Aandelen stijgen Pre-Bell	MT
08/05	Transcript : Vericel Corporation, Q1 2024 Earnings Call, May 08, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell	08/05
Earnings Flash (VCEL) VERICEL CORPORATION Posts Q1 Revenue $51.3M, vs. Street Est of $49.1M	08/05
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance	08/05
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Vericel Corporation Provides Earnings Guidance for the Year 2024	08/05
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024	24/04
Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	19/04
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	15/03
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	13/03
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	11/03
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	29/02
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	29/02
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q4 Revenue $65M, vs. Street Est of $64M	29/02
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29/02
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29/02
North American Morning Briefing : Fed's Preferred -2-	29/02
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27/02
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aastrom Biosciences Inc Nasdaq

Aandelen

US00253U3059

Andere talen

Filters